Vascular endothelial growth factor signaling in acute myeloid leukemia.
about
Endothelial progenitor cells in hematologic malignanciesUp-regulation of VEGF and its receptor in refractory leukemia cells.SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia.De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.Angiogenesis and acute myeloid leukemia.miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.Antileukemic effects of midostaurin in acute myeloid leukemia - the possible importance of multikinase inhibition in leukemic as well as nonleukemic stromal cells.Myeloid malignancies and the microenvironment.Levels of bone marrow microvessel density are crucial for evaluating the status of acute myeloid leukemia.Increased Vascular Permeability in the Bone Marrow Microenvironment Contributes to Disease Progression and Drug Response in Acute Myeloid LeukemiaPeptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML.Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene.Suppression of HSP27 increases the anti‑tumor effects of quercetin in human leukemia U937 cellsMesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular MechanismsMonocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells.Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent.Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells
P2860
Q28073331-7E8E2E81-6A56-4B09-BD38-D4E45CB28DB4Q35854134-9D3949C7-065B-4551-A90F-BC1EB4E131F9Q36996528-C40B7DB3-A04E-4393-9031-026ADB500198Q37584726-81416DB6-148A-4974-A762-AEE4E4D2A04EQ38160129-3E54C40C-68C0-4706-84E3-A4144141F3DFQ39039867-4075FD4F-37F7-46D8-B182-644CDD5DFB71Q39045977-239B76BB-7F03-4ACD-B559-75B3B85B372FQ39073878-1BBED9A1-A16B-4763-926D-2D5568608F57Q40741428-067D0276-7C17-48E5-812E-992E99CA5B03Q41089780-E83D3855-3F3A-4622-A2F2-0BF2543C37D3Q41815540-DB290FC0-670D-4EEF-A2B2-3A77F6B1A0A9Q41869300-9153D4A0-BE03-4060-AA4E-146E3737C898Q42068149-19669679-AD89-442F-8449-FB74C814CC4BQ42262053-F3022FAB-4CB2-45EC-A48F-8662F29193A3Q47111427-D633943B-82DF-467A-AED4-ECF82DE01316Q47339574-15513D86-29A0-4E81-A040-5FFCB1543794Q52681013-B6F3A0A3-C7AF-47F6-9F3C-CA4F12FCF0C4Q54309194-62DC6875-97E1-4C20-8700-AFB74B986B1EQ55643012-1C8B4ECC-CE8B-4AEF-9694-06C10C9EFA1A
P2860
Vascular endothelial growth factor signaling in acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vascular endothelial growth factor signaling in acute myeloid leukemia.
@en
type
label
Vascular endothelial growth factor signaling in acute myeloid leukemia.
@en
prefLabel
Vascular endothelial growth factor signaling in acute myeloid leukemia.
@en
P2860
P1476
Vascular endothelial growth factor signaling in acute myeloid leukemia.
@en
P2093
Arja Ter Elst
Eveline S J M de Bont
P2860
P2888
P304
P356
10.1007/S00018-012-1085-3
P50
P577
2012-07-26T00:00:00Z